Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Piramal Pharma: Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Ratings
News Announcement

Piramal Pharma: Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Ratings

20-Mar-2026 Follow Value Research Online on Google download pdfDownload PDF Piramal Pharma

Please refer attached file

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.